190 related articles for article (PubMed ID: 18404881)
1. [Clinical characteristics of prostatic adenocarcinoma with ductal features].
Yamashita R; Matsuzaki M; Matsui T; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K
Nihon Hinyokika Gakkai Zasshi; 2008 Mar; 99(3):525-30. PubMed ID: 18404881
[TBL] [Abstract][Full Text] [Related]
2. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
3. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.
Brinker DA; Potter SR; Epstein JI
Am J Surg Pathol; 1999 Dec; 23(12):1471-9. PubMed ID: 10584700
[TBL] [Abstract][Full Text] [Related]
4. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
Amin A; Epstein JI
Am J Surg Pathol; 2011 Apr; 35(4):615-9. PubMed ID: 21383610
[TBL] [Abstract][Full Text] [Related]
5. [Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].
Feyaerts A; Delrée A; Lorge F; Opsomer RJ; Wese FX; Van Cangh PJ; Draguet AP; Cosyns JP
Acta Urol Belg; 1997 Mar; 65(1):11-8. PubMed ID: 9245198
[TBL] [Abstract][Full Text] [Related]
6. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS
J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805
[TBL] [Abstract][Full Text] [Related]
8. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
10. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
[TBL] [Abstract][Full Text] [Related]
11. Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer.
Aprikian AG; Fair WR; Reuter VE; Sogani P; Herr H; Russo P; Sheinfeld J
Br J Urol; 1994 Nov; 74(5):630-6. PubMed ID: 7530128
[TBL] [Abstract][Full Text] [Related]
12. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.
Tarján M; Chen HH; Tot T; Wu W; Lenngren A; Dean PB; Tabár L
Scand J Urol Nephrol; 2012 Aug; 46(4):258-66. PubMed ID: 22519924
[TBL] [Abstract][Full Text] [Related]
13. [Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital].
Nakamura K; Terada N; Kobayashi T; Sugino Y; Yamasaki T; Matsui Y; Imamura M; Okubo K; Kamba T; Yoshimura K; Ogawa O
Hinyokika Kiyo; 2015 Dec; 61(12):487-91. PubMed ID: 26790762
[TBL] [Abstract][Full Text] [Related]
14. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
[TBL] [Abstract][Full Text] [Related]
15. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
16. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
17. Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.
Samaratunga H; Duffy D; Yaxley J; Delahunt B
Hum Pathol; 2010 Feb; 41(2):281-5. PubMed ID: 20004936
[TBL] [Abstract][Full Text] [Related]
18. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
Stamey TA
Urologe A; 1990 Mar; 29(2):52-64. PubMed ID: 1691883
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
20. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
